Matches in Wikidata for { <http://www.wikidata.org/entity/Q37048614> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q37048614 description "article científic" @default.
- Q37048614 description "article scientifique" @default.
- Q37048614 description "articolo scientifico" @default.
- Q37048614 description "artigo científico" @default.
- Q37048614 description "artículu científicu espublizáu en 2008" @default.
- Q37048614 description "bilimsel makale" @default.
- Q37048614 description "scientific article published on January 2008" @default.
- Q37048614 description "vedecký článok" @default.
- Q37048614 description "vetenskaplig artikel" @default.
- Q37048614 description "videnskabelig artikel" @default.
- Q37048614 description "vědecký článek" @default.
- Q37048614 description "wetenschappelijk artikel" @default.
- Q37048614 description "wissenschaftlicher Artikel" @default.
- Q37048614 description "наукова стаття, опублікована в січні 2008" @default.
- Q37048614 description "научни чланак" @default.
- Q37048614 description "مقالة علمية نشرت في يناير 2008" @default.
- Q37048614 name "Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy." @default.
- Q37048614 name "Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy." @default.
- Q37048614 name "Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy." @default.
- Q37048614 type Item @default.
- Q37048614 label "Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy." @default.
- Q37048614 label "Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy." @default.
- Q37048614 label "Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy." @default.
- Q37048614 prefLabel "Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy." @default.
- Q37048614 prefLabel "Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy." @default.
- Q37048614 prefLabel "Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy." @default.
- Q37048614 P1433 Q37048614-6EA19A9F-C0E6-4C26-906F-74DE5A4B593A @default.
- Q37048614 P1476 Q37048614-95A6DEBC-D58F-409F-8765-AB2E90DB12D3 @default.
- Q37048614 P2093 Q37048614-A030408F-3064-4650-A115-01CC2C563278 @default.
- Q37048614 P304 Q37048614-B8D226C8-8212-4DDE-B221-BE8C5D014812 @default.
- Q37048614 P31 Q37048614-6E0B04F5-EAD5-487B-8EEE-61845F6E957F @default.
- Q37048614 P433 Q37048614-8B8F1E24-D56E-486C-8E88-E097FFAD4457 @default.
- Q37048614 P478 Q37048614-748D76C4-823F-47CD-A71E-B46E138AF854 @default.
- Q37048614 P577 Q37048614-EF0D6E65-4886-4505-99D6-B23653BB7554 @default.
- Q37048614 P698 Q37048614-1DEC31FA-241C-4D01-B5AD-E1CA697E892F @default.
- Q37048614 P698 18170999 @default.
- Q37048614 P1433 Q15756319 @default.
- Q37048614 P1476 "Review: effectiveness of ACE inhibitors is similar across various baseline risks for disease progression in nondiabetic nephropathy" @default.
- Q37048614 P2093 "Maurice Laville" @default.
- Q37048614 P304 "12" @default.
- Q37048614 P31 Q13442814 @default.
- Q37048614 P433 "1" @default.
- Q37048614 P478 "148" @default.
- Q37048614 P577 "2008-01-01T00:00:00Z" @default.
- Q37048614 P698 "18170999" @default.